Stay updated on FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial

Sign up to get notified when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Difference
    0.6%
    Check dated 2024-12-22T07:55:58.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.4%
    Check dated 2024-12-15T00:26:00.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, clarifying that it now provides information for individuals who can answer questions about joining the study and includes a reference to the Contacts and Locations section.
    Difference
    3%
    Check dated 2024-12-07T21:53:33.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-11-30T17:00:16.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Several links related to chronic lymphocytic leukemia, lymphoma, and other rare diseases have been removed, indicating a potential shift in focus or resource availability on the website.
    Difference
    6%
    Check dated 2024-11-23T06:17:47.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    New resources related to leukemia, lymphoma, and chronic graft-versus-host disease have been added, including links to MedlinePlus and Rare Diseases information.
    Difference
    1%
    Check dated 2024-11-16T01:53:38.000Z thumbnail image

Stay in the know with updates to FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial

Enter your email address, and we'll notify you when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.